CIBC World Market
NKTR icon

CIBC World Market’s Nektar Therapeutics NKTR Stock Holding History

CIBC World Market’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,282
Closed -$562K – 1569
2025
Q4 		$562K Buy
+13,282
New +$743K ﹤0.01% 1090
2019
Q4 		– Sell
-1,897
Closed -$518K – 1194
2019
Q3 		$518K Sell
1,897
-96
-5% -$35.2K ﹤0.01% 790
2019
Q2 		$1.06M Sell
1,993
-37
-2% -$18.6K ﹤0.01% 629
2019
Q1 		$1.02M Buy
2,030
+6
+0.3% +$3.56K ﹤0.01% 656
2018
Q4 		$998K Buy
+2,024
New +$1.22M 0.01% 607

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIBC World Market's NKTR Position: Q1 2026 in Review

CIBC World Market sold out of Nektar Therapeutics (NKTR) in Q1 2026, closing a stake of 13,282 shares — an estimated $562K sold.

CIBC World Market first reported a position in NKTR in Q4 2018 and held it in 5 quarters. The position peaked at $1.06M in Q2 2019. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • CIBC World Market reported no remaining Nektar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • CIBC World Market sold 13,282 Nektar Therapeutics shares in Q1 2026, an estimated $562K.
  • CIBC World Market first reported a position in Nektar Therapeutics in Q4 2018 and held it in 5 quarters.
  • CIBC World Market's Nektar Therapeutics position peaked at $1.06M in Q2 2019.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.